As the demands for faster, more accurate, and scalable literature reviews rise in life sciences, AI is no longer just a future promise—it’s a proven performance driver. Systematic literature review (SLR) teams, especially in HEOR and medical affairs, are adopting GenAI platforms not just for experimentation but to solve long-standing bottlenecks in screening, extraction, and…
At the ISPOR 2024 Conference in Atlanta, attending health economics and outcomes research (HEOR) professionals lamented the drudgery of systematic literature reviews (SLRs) as they envisioned the potential for generative artificial intelligence (GenAI) to fix it. With a single SLR estimated to take anywhere from six to 16 months to complete and cost an average…
AI has become an integral part of the life sciences landscape, contributing to advancements in diagnosis, treatment, and overall healthcare delivery. But many worry that without proper government oversight, the use of AI and machine learning (ML) algorithms could also cause negative and unintended consequences, including critical errors and bias amplification. That’s why many international…
